Empagliflozin vs Finasteride
Empagliflozin vs Finasteride: Overview
This comparison examines the pharmacological differences between Empagliflozin and Finasteride.
Mechanism of Action
Empagliflozin: Selective SGLT2 inhibitor reducing renal glucose reabsorption.
Finasteride: Competitive inhibitor of 5-alpha-reductase type II.
Pharmacokinetics
Half-life: Empagliflozin β 12.4 hours; Finasteride β 5-6 hours.
Chemical Properties
Molecular Formula: Empagliflozin β C23H27ClO7; Finasteride β C23H36N2O2.
Molecular Weight: Empagliflozin β 450.9100 g/mol; Finasteride β 372.5490 g/mol.
Type: Empagliflozin β Small molecule; Finasteride β Small molecule.